Clinical application of carbon nanoparticles labeled lymph node in cervical lymph node dissection with papillary thyroid cancer staged preoperatively as N0
-
摘要: 目的:探讨纳米碳示踪剂在甲状腺乳头状癌(cN0期)颈部淋巴结清扫中的应用价值。方法:将100例符合入选标准的甲状腺乳头状癌(cN0期)患者随机分为纳米碳组(50例)和常规手术组(50例),两组患者均予腺叶切除、甲状腺近全切除或甲状腺全切除,均进行中央区淋巴结清扫,统计各组检获淋巴结数,并将纳米碳组检获的淋巴结按染色与未染色统计,分别进行病理检查。结果:纳米碳组每例检出淋巴结数明显高于常规手术组(P<0.05);纳米碳组每例检出转移淋巴结枚数高于常规手术组(P<0.01)。100例患者中有2%出现了暂时性声嘶,8%暂时性甲状旁腺功能低下,无永久性声嘶及永久性甲状旁腺功能低下等并发症。结论:纳米碳淋巴结示踪剂染色效果良好,术中易识别,能指导手术医师术中正确制定手术方案进行淋巴结清除。Abstract: Objective:To investigate the clinical application of carbon nanoparticles staining in cervical lymph node dissection on clinical neck lymph nodes the negative (cN0 period) thyroid papillary thyroid carcinoma (PTC). Method:This retrospective analysis comprised 100 papillary thyroid cancer patients who met inclusion criteria,and they were randomly divided into the nano-carbon group (50 cases) and control group (50 cases).They underwent lobectomy,subtotal thyroidectomy or total thyroidectomies and were given elective central compartment neck dissection (CCND). The number of detected lymph nodes in each group was summed, and pathological examination was conducted. The number of lymph nodes (dyedor not dyed) and the location of metastatic nodes were recorded separately.Result:In the nano-carbon group the average number of eliminated lymph nodes is significantly more than that of the control group(P<0.05). The metastasis lymph nodes in the nano-carbon group was higher than that in the control group(P<0.01).Among 100 cases, 2% had temporary vocal cord palsy, and 8% had temporary hypoparat hyroidism. No case of permanent vocal cord palsy or permanent hypocalcemia was observed.Conclusion:The dyed lymph nodes can be easily identified and can be used as a guide for lymphnodes dissection in papillary thyroid carcinoma operation.
-
Key words:
- carbon nanoparticles /
- papillary thyroid carcinoma /
- parathyroid /
- lymph node dissection
-
-
[1] 章阳, 崔兆清, 孙善平, 等.分化型甲状腺癌行颈部淋巴结清扫的意义及方式探讨[J].中国实用外科杂志, 2011, 31 (5):414-416.
[2] 滕卫平, 刘永锋, 高明, 等.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床, 2012, 39 (17):1249-1272.
[3] BAEK S K, JUNG K Y, KANG S M, et al.Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma[J].Thyroid, 2010, 20:147-152.
[4] 马宏岩, 李迅庚.甲状腺乳头状癌选择性颈淋巴结清除术的临床研究[J].中华肿瘤防治研究, 2008, 15 (6):453-455.
[5] KOUVARAKI M A, SHAPIRO S E, FORNAGE B D, et al.Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer[J].Surgery, 2003, 134:946-955.
[6] PODNOS Y D, SMITH D, WAGMAN L D, et al.The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer[J].Am Surg, 2005, 71:731-734.
[7] LUNDGREN C I, HALL P, DICKMAN P W, et al.Clinically significant prognostic factors for differentiated thyroid carcinoma:a population-based, nested case-control study[J].Cancer, 2006, 106:524-531.
[8] HAGIWARA A, TORII T, SAWAI K, et al.Local injection of anti-cancer drugs bound to carbon particles for early gastric cancer——apilot study[J].Hepatogastroenterology, 2000, 47:575-578.
[9] 林周, 鲍传庆, 俞宪民, 等.纳米碳标记淋巴结和前哨淋巴结的活检在大肠癌根治术应用研究[J].实用临床药物杂志, 2007, 11 (9):80-81.
[10] 李伟, 徐亮.纳米碳在胃癌淋巴靶向化疗中的应用研究进展[J].泸州医学院学报, 2009, 32 (4):439-441.
[11] 张筱骅, 郝儒田, 尤捷, 等.甲状腺淋巴管造影在鉴别甲状旁腺中的意义[J].温州医学院学报, 2010, 40 (1):31-35.
-
计量
- 文章访问数: 217
- PDF下载数: 143
- 施引文献: 0